It balances the sympathetic and parasympathetic nervous systems
PMID: 6066618
Why AOD-9604 Was Designed for Continuous Use From a pharmaceutical development standpoint: Cycling complicates compliance Cycling introduces variability Cycling reduces predictability Drugs intended for obesity management are not designed to be cycled
Important Note: These potential benefits are based primarily on animal data and anecdotal use, not clinical trials in women
Dissociated cells were suspended in L-15 medium (Liebovitz, L1518, Merck) containing 10% fetal bovine serum, NaHCO 3 , glucose, penicillin/streptomycin (1) and floxuridine (PHR2589, Merck) and plated on coverslips precoated with poly-d-lysine (A-003-E, Merck) and laminin (L2020, Merck)
Used in regulating the immune system in autoimmune conditions